COPD Australia - Search News

ENA Respiratory doses first participants in phase II study of INNA-051 to protect against symptomatic viral respiratory infections

Melbourne, Australia Saturday, January 31, 2026, 16:00 Hrs [IST] ...

Some results have been hidden because they may be inaccessible to you